Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131857) titled 'A Single-Center, Prospective, Non-Interventional Observational Study of Bevacizumab-Containing Regimens Combined with Hyperthermia for Multiple Cancer Types' on Sept. 7.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: People's Hospital of Zhengzhou
Condition:
Non-squamous non-small cell lung cancerns,Ovarian cancer, Colorectal cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-07
Target Sample Size: Observation group (receive treatment with bevacizumab combined with hyperthermia):60;
Countries of Recruitment:
China
To know more, visi...